Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

Llovet JM, Peña CE, Lathia CD, Shan M, Meinhardt G, Bruix J; SHARP Investigators Study Group.

Clin Cancer Res. 2012 Apr 15;18(8):2290-300. doi: 10.1158/1078-0432.CCR-11-2175. Epub 2012 Feb 28.

2.

Sorafenib in advanced hepatocellular carcinoma.

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group.

N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.

Supplemental Content

Loading ...
Support Center